Billiontoone (NASDAQ:BLLN) Trading Down 5.7% – Should You Sell?

Billiontoone, Inc. (NASDAQ:BLLN)’s stock price traded down 5.7% during mid-day trading on Wednesday . The company traded as low as $77.55 and last traded at $78.40. 101,877 shares traded hands during mid-day trading, a decline of 57% from the average session volume of 237,485 shares. The stock had previously closed at $83.14.

Wall Street Analysts Forecast Growth

Several brokerages have recently commented on BLLN. Stifel Nicolaus began coverage on Billiontoone in a report on Monday, December 1st. They set a “buy” rating and a $145.00 target price on the stock. Zacks Research upgraded shares of Billiontoone to a “hold” rating in a research report on Tuesday, December 2nd. Piper Sandler reissued an “overweight” rating on shares of Billiontoone in a report on Wednesday, December 10th. Wells Fargo & Company began coverage on shares of Billiontoone in a research note on Monday, December 1st. They issued an “equal weight” rating and a $110.00 target price for the company. Finally, William Blair assumed coverage on shares of Billiontoone in a research note on Monday, December 1st. They set an “outperform” rating on the stock. Six equities research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $135.29.

Billiontoone Price Performance

The stock has a market capitalization of $3.66 billion and a PE ratio of 799.50. The business has a fifty day moving average price of $86.26.

Billiontoone (NASDAQ:BLLN) last announced its quarterly earnings data on Tuesday, December 9th. The company reported $0.10 earnings per share for the quarter, missing the consensus estimate of $0.16 by ($0.06). The company had revenue of $83.52 million for the quarter, compared to analyst estimates of $82.86 million.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of BLLN. Rossby Financial LCC acquired a new position in shares of Billiontoone in the 4th quarter valued at $25,000. Wells Fargo & Company MN bought a new position in Billiontoone during the fourth quarter worth about $76,000. Smartleaf Asset Management LLC bought a new position in Billiontoone during the fourth quarter worth about $80,000. Nano Cap New Millennium Growth Fund L P bought a new stake in shares of Billiontoone in the fourth quarter worth about $82,000. Finally, Renaissance Capital LLC bought a new stake in shares of Billiontoone in the fourth quarter worth about $201,000.

Billiontoone Company Profile

BillionToOne (NASDAQ: BLLN) is a molecular diagnostics company that develops and commercializes high-precision genetic testing solutions based on single-molecule counting technology. The company’s platform is designed to detect and quantify rare genetic variants and chromosomal abnormalities from cell-free DNA, with a primary focus on applications in prenatal screening and other clinical genetic tests where sensitivity and specificity at very low allele fractions are critical.

BillionToOne’s offerings center on assay development and clinical testing workflows that enable non-invasive prenatal testing (NIPT) and targeted molecular diagnostics.